Piracetam is the parent compound of the racetam class of nootropics, synthetic derivatives of the neurotransmitter GABA. It is thought to enhance cognitive function by improving neuronal membrane fluidity and modulating neurotransmitter systems like acetylcholine. Its relevance to healthspan is speculative, focusing on the potential preservation of cognitive function rather than systemic longevity.
Verdict
Speculative cognitive enhancer with no proven impact on overall healthspan.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
Low
EVIDENCE GRADE
B
MONTHLY COST
$15 - $40
Protocol
- Daily dosages typically range from 1.6 to 4.8 grams, often divided into two or three administrations.
Flags
- Not approved by the FDA for medical use in the United States.
- May cause psychomotor agitation, anxiety, and insomnia in some individuals.
- Use with caution in individuals with severe renal impairment as it is cleared by the kidneys.
- May increase effects of anticoagulant drugs; use with caution.